Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20253882

Company云南龙津康佑生物医药有限公司

Registration Date

April 15, 2025

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg与苯磺酸氨氯地平5mg（按 C₂₀H₂₅ClN₂O₅计）

Drug Type

化学药品

Registration Date

April 15, 2025

Company Information

Applicant Company

Company Name云南龙津康佑生物医药有限公司

Company Address

云南省昆明高新区百大国际派1栋12层10号

Manufacturing Company

Company Name昆明龙津药业股份有限公司

Company Address

云南省昆明市昆明高新区马金铺街道办事处兰茂路789号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy